← Open Payments lookup

FRANCESCO IACOBELLI: Open Payments

NPI 1750737706 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$893 in 42 payments from 16 companies in 2025. Trend: 2023 $805 · 2024 $1,007 · 2025 $893

Food & beverage: $893
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$112
Corium, LLC5$107
E.R. Squibb & Sons, L.L.C.4$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$88
Axsome Therapeutics, Inc.3$77
ABBVIE INC.3$72
Collegium Pharmaceutical, Inc.3$66
Otsuka America Pharmaceutical, Inc.3$62
Teva Pharmaceuticals USA, Inc.3$50
Janssen Pharmaceuticals, Inc1$34

Products named: INGREZZA, Azstarys, COBENFY, CAPLYTA, Auvelity, VRAYLAR, REXULTI, Jornay PM.

Industry payments across MI — which companies pay providers there.